2ccPA Study in Patients With Symptomatic Knee Osteoarthritis

NCT04229394 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis (OA) of the Knee

Interventions

DRUG: 2ccPA
DRUG: placebo

Sponsor

Orient Europharma Co., Ltd.